Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,494 | 57 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $575.00 | 23 | $0 (2024) |
| Gilead Sciences, Inc. | $439.60 | 10 | $0 (2023) |
| ViiV Healthcare Company | $405.17 | 9 | $0 (2024) |
| Allergan, Inc. | $287.80 | 4 | $0 (2022) |
| Abbott Laboratories | $180.77 | 1 | $0 (2021) |
| Coloplast Corp | $140.67 | 2 | $0 (2020) |
| TissueTech, Inc. | $112.51 | 1 | $0 (2018) |
| Boston Scientific Corporation | $95.24 | 1 | $0 (2020) |
| Apyx Medical Corporation | $89.33 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $55.73 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $286.86 | 12 | ABBVIE INC. ($252.19) |
| 2023 | $351.99 | 13 | ABBVIE INC. ($251.13) |
| 2022 | $381.56 | 7 | Allergan, Inc. ($221.09) |
| 2021 | $430.64 | 8 | Abbott Laboratories ($180.77) |
| 2020 | $438.80 | 10 | Gilead Sciences, Inc. ($96.34) |
| 2019 | $255.36 | 3 | Gilead Sciences, Inc. ($130.36) |
| 2018 | $230.80 | 2 | Gilead Sciences, Inc. ($118.29) |
| 2017 | $117.71 | 2 | Coloplast Corp ($96.23) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: VIROLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $33.02 | General |
| Category: VIROLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: VIROLOGY | ||||||
| 10/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/16/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: VIROLOGY | ||||||
| 06/27/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $34.18 | General |
| Category: VIROLOGY | ||||||
| 05/29/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $32.66 | General |
| Category: VIROLOGY | ||||||
| 04/30/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $32.58 | General |
| Category: VIROLOGY | ||||||
| 04/30/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: VIROLOGY | ||||||
| 03/16/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $34.67 | General |
| Category: HIV | ||||||
| 03/13/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: VIROLOGY | ||||||
| 01/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $31.07 | General |
| Category: VIROLOGY | ||||||
| 11/07/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: VIROLOGY | ||||||
| 11/07/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: VIROLOGY | ||||||
| 09/07/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $82.67 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/06/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $33.54 | General |
| Category: VIROLOGY | ||||||
| 07/11/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: VIROLOGY | ||||||
| 06/20/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Cardio-renal | ||||||
| 05/08/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.47 | General |
| 04/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Cardio-renal | ||||||
| 04/05/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $28.37 | General |
| Category: VIROLOGY | ||||||
| 03/06/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: VIROLOGY | ||||||
| 03/06/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $0.95 | General |
| Category: VIROLOGY | ||||||
| 02/10/2023 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: HIV | ||||||
| 02/02/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: VIROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 106 | 176 | $39,720 | $14,212 |
| 2022 | 5 | 161 | 274 | $52,555 | $20,315 |
| 2021 | 3 | 132 | 233 | $46,920 | $14,848 |
| 2020 | 3 | 159 | 298 | $58,450 | $14,363 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 60 | $16,500 | $5,381 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 84 | $15,540 | $4,579 | 29.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 32 | 32 | $7,680 | $4,252 | 55.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 80 | $22,000 | $7,482 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 112 | $20,720 | $7,139 | 34.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 37 | 37 | $8,880 | $5,100 | 57.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 28 | 28 | $700.00 | $538.39 | 76.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 14 | 17 | $255.00 | $55.44 | 21.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 83 | $22,825 | $8,496 | 37.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 58 | 107 | $19,795 | $5,949 | 30.1% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2021 | 36 | 43 | $4,300 | $404.04 | 9.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 74 | 160 | $29,600 | $7,421 | 25.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 42 | 86 | $23,650 | $6,378 | 27.0% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 43 | 52 | $5,200 | $564.10 | 10.8% |
About Dr. Guy Moise, DO
Dr. Guy Moise, DO is a General Practice healthcare provider based in North Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1366431983.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Guy Moise, DO has received a total of $2,494 in payments from pharmaceutical and medical device companies, with $286.86 received in 2024. These payments were reported across 57 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,494).
As a Medicare-enrolled provider, Moise has provided services to 558 Medicare beneficiaries, totaling 981 services with total Medicare billing of $63,738. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Other Specialties Family Medicine
- Location North Miami, FL
- Active Since 10/17/2005
- Last Updated 02/23/2024
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1366431983
Products in Payments
- MAVYRET (Drug) $469.58
- DOVATO (Drug) $381.46
- Truvada (Drug) $233.09
- BOTOX (Biological) $205.73
- Merlin Connectivity and Remote (Device) $180.77
- Prokera (Device) $112.51
- SUPRIS (Device) $96.23
- LYNX (Device) $95.24
- BOTOX COSMETIC (Biological) $66.71
- Kerendia (Drug) $46.68
- TITAN (Device) $44.44
- ERLEADA (Drug) $43.74
- Descovy (Drug) $29.37
- APRETUDE (Biological) $23.71
- SUBOXONE SUBLINGUAL FILM (Drug) $21.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in North Miami
Carlos Espinal Mercado
General Practice — Payments: $7,673
Dr. Evelyn Aldama, Dds, DDS
General Practice — Payments: $1,605
Dr. Maria Fermin, D.m.d, D.M.D
General Practice — Payments: $1,263
Dr. Damaysi Jimenez Rojas, Md, MD
General Practice — Payments: $1,105
Dr. Sylvan Fain, Dds, DDS
General Practice — Payments: $982.71
Elizabeth Medrano, Md, MD
General Practice — Payments: $598.36